Previous 10 | Next 10 |
home / stock / bhsc:cc / bhsc:cc news
Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 Million Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host ...
--News Direct-- BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share the company's impressive financial and operational results for the fourth quarter and full year ended December 31, 2023. Revenue surged by 131% to $12.7 million in 2023, compared to $5.5 millio...
FY 2023 Revenue Increased 2.3x to $12.7 Million USD The Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 million Management pursuing Nasdaq listing by end of year. General and Special meeting called to ...
--News Direct-- BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to to unveil two significant agreements that mark a transformative milestone for the company: an equipment purchase agreement for 12 state-of-the-art GMP clean rooms and a long-term lease agreement for ...
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded 50 Ton Manufacturing facility New Production Technologies Implemented at this Campus will serve to optimize the planned US-based 150-ton manufacturing facili...
2024-03-27 17:08:02 ET It isn’t often that a company surfaces with real breakthrough potential. BioHarvest could be one of them. BioHarvest is a biotech company unlocking the cellular biological secrets of plants and fruits to bring wellness to consumers. It all revolves arou...
--News Direct-- BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to announce two key appointments in the areas of business development and science to lead important initiatives within the company's newly launched CDMO Services Business Unit. Sobel introduced Matt...
Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biote...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it has bee...
News, Short Squeeze, Breakout and More Instantly...
Bioharvest Sciences Inc. Company Name:
BHSC:CC Stock Symbol:
CNQC Market:
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of BioHarvest Sciences Inc. (OTCQB: CNVCF, CSE: BHSC). The in-depth 35-page initiation report includes detailed informat...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) ("BioHarvest" or the "Company") has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 sh...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present a...